Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chlamydia Infections | 19 | 2024 | 196 | 4.780 |
Why?
|
| Chlamydia | 9 | 2023 | 42 | 2.590 |
Why?
|
| Chlamydia muridarum | 5 | 2021 | 104 | 1.650 |
Why?
|
| Plasmodium falciparum | 9 | 2015 | 135 | 1.310 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2018 | 103 | 1.130 |
Why?
|
| Chlamydia trachomatis | 7 | 2024 | 68 | 1.090 |
Why?
|
| Merozoite Surface Protein 1 | 5 | 2010 | 35 | 1.090 |
Why?
|
| Receptors, KIR | 2 | 2018 | 5 | 1.050 |
Why?
|
| Bacterial Vaccines | 7 | 2024 | 125 | 1.030 |
Why?
|
| Dendritic Cells | 5 | 2021 | 113 | 1.000 |
Why?
|
| Polymorphism, Genetic | 2 | 2018 | 191 | 0.960 |
Why?
|
| Vagina | 3 | 2023 | 81 | 0.930 |
Why?
|
| Pelvic Inflammatory Disease | 2 | 2020 | 19 | 0.880 |
Why?
|
| Genitalia | 2 | 2019 | 17 | 0.820 |
Why?
|
| Antibodies, Protozoan | 6 | 2010 | 79 | 0.800 |
Why?
|
| Malaria, Falciparum | 8 | 2015 | 90 | 0.750 |
Why?
|
| HIV Infections | 3 | 2023 | 2303 | 0.730 |
Why?
|
| Mice | 21 | 2024 | 5913 | 0.700 |
Why?
|
| Malaria | 2 | 2012 | 78 | 0.690 |
Why?
|
| MicroRNAs | 4 | 2021 | 426 | 0.630 |
Why?
|
| Circadian Rhythm | 1 | 2020 | 225 | 0.620 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2018 | 72 | 0.590 |
Why?
|
| Immunoglobulin G | 3 | 2010 | 237 | 0.590 |
Why?
|
| Animals | 27 | 2024 | 15081 | 0.560 |
Why?
|
| Interleukin-10 | 2 | 2017 | 75 | 0.550 |
Why?
|
| Mice, Inbred C57BL | 11 | 2023 | 1609 | 0.530 |
Why?
|
| Fertility | 1 | 2015 | 59 | 0.520 |
Why?
|
| Female | 25 | 2024 | 20969 | 0.490 |
Why?
|
| Epitopes | 3 | 2024 | 148 | 0.460 |
Why?
|
| Carrier Proteins | 1 | 2015 | 305 | 0.450 |
Why?
|
| Antibody Specificity | 2 | 2010 | 79 | 0.420 |
Why?
|
| Antibodies, Blocking | 3 | 2010 | 11 | 0.410 |
Why?
|
| Placenta | 1 | 2012 | 97 | 0.400 |
Why?
|
| Killer Cells, Natural | 1 | 2012 | 92 | 0.400 |
Why?
|
| Pregnancy | 6 | 2023 | 1549 | 0.380 |
Why?
|
| Immunoglobulin M | 2 | 2010 | 82 | 0.380 |
Why?
|
| Photoperiod | 2 | 2020 | 26 | 0.360 |
Why?
|
| Antibodies, Bacterial | 4 | 2024 | 109 | 0.340 |
Why?
|
| Protozoan Proteins | 4 | 2012 | 182 | 0.330 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 1371 | 0.330 |
Why?
|
| Host-Pathogen Interactions | 3 | 2021 | 186 | 0.320 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2024 | 57 | 0.320 |
Why?
|
| Unfolded Protein Response | 2 | 2018 | 18 | 0.310 |
Why?
|
| Humans | 19 | 2024 | 37093 | 0.270 |
Why?
|
| Protein Subunits | 1 | 2005 | 87 | 0.260 |
Why?
|
| Vibrio cholerae | 4 | 2021 | 98 | 0.250 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2018 | 189 | 0.250 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 1015 | 0.250 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2024 | 12 | 0.240 |
Why?
|
| Africa | 1 | 2023 | 76 | 0.230 |
Why?
|
| Antimalarials | 2 | 2015 | 55 | 0.220 |
Why?
|
| Child, Preschool | 6 | 2015 | 1418 | 0.220 |
Why?
|
| Drug Resistance | 2 | 2015 | 99 | 0.220 |
Why?
|
| Infant | 5 | 2015 | 1046 | 0.220 |
Why?
|
| Uterus | 1 | 2023 | 55 | 0.220 |
Why?
|
| Transforming Growth Factor beta | 2 | 2020 | 197 | 0.190 |
Why?
|
| Infant, Newborn | 3 | 2010 | 894 | 0.190 |
Why?
|
| Cell Line | 3 | 2020 | 1354 | 0.190 |
Why?
|
| Pregnancy, Ectopic | 1 | 2020 | 14 | 0.190 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2015 | 448 | 0.190 |
Why?
|
| Signal Transduction | 3 | 2020 | 1908 | 0.190 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2024 | 62 | 0.180 |
Why?
|
| Adoptive Transfer | 2 | 2021 | 48 | 0.180 |
Why?
|
| Antigen Presentation | 3 | 2017 | 54 | 0.180 |
Why?
|
| Child | 7 | 2015 | 3131 | 0.180 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2019 | 4 | 0.170 |
Why?
|
| Immunity, Mucosal | 1 | 2019 | 47 | 0.170 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 626 | 0.160 |
Why?
|
| Biopsy | 1 | 2019 | 164 | 0.160 |
Why?
|
| Mice, Knockout | 3 | 2017 | 933 | 0.160 |
Why?
|
| Adolescent | 7 | 2015 | 5363 | 0.150 |
Why?
|
| Genotype | 2 | 2018 | 730 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2021 | 517 | 0.150 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2017 | 33 | 0.150 |
Why?
|
| Haplotypes | 1 | 2018 | 182 | 0.150 |
Why?
|
| Fibrosis | 1 | 2017 | 159 | 0.140 |
Why?
|
| Epithelial Cells | 1 | 2020 | 384 | 0.140 |
Why?
|
| Computational Biology | 1 | 2019 | 293 | 0.140 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 893 | 0.140 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2015 | 4 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2017 | 194 | 0.130 |
Why?
|
| Cross Protection | 1 | 2015 | 4 | 0.130 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 70 | 0.130 |
Why?
|
| Malaria Vaccines | 3 | 2010 | 21 | 0.130 |
Why?
|
| Nigeria | 3 | 2009 | 86 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 539 | 0.110 |
Why?
|
| Apoptosis | 3 | 2017 | 1398 | 0.110 |
Why?
|
| Caspase 1 | 1 | 2013 | 15 | 0.110 |
Why?
|
| Adult | 5 | 2018 | 11712 | 0.110 |
Why?
|
| Infertility, Female | 1 | 2013 | 24 | 0.110 |
Why?
|
| Sulfadoxine | 1 | 2012 | 6 | 0.110 |
Why?
|
| Pyrimethamine | 1 | 2012 | 10 | 0.110 |
Why?
|
| Calcium | 1 | 2015 | 480 | 0.110 |
Why?
|
| Mutation, Missense | 2 | 2012 | 83 | 0.100 |
Why?
|
| Caspase 3 | 1 | 2013 | 207 | 0.100 |
Why?
|
| HIV-1 | 1 | 2018 | 706 | 0.100 |
Why?
|
| Genetic Loci | 1 | 2012 | 90 | 0.100 |
Why?
|
| Cross-Sectional Studies | 3 | 2010 | 2721 | 0.100 |
Why?
|
| Alleles | 1 | 2012 | 321 | 0.100 |
Why?
|
| Young Adult | 3 | 2018 | 4268 | 0.100 |
Why?
|
| Seasons | 2 | 2015 | 112 | 0.090 |
Why?
|
| Cytokines | 2 | 2017 | 602 | 0.090 |
Why?
|
| Hela Cells | 3 | 2018 | 366 | 0.090 |
Why?
|
| Vaccines, Subunit | 2 | 2023 | 30 | 0.090 |
Why?
|
| Inclusion Bodies | 2 | 2020 | 33 | 0.090 |
Why?
|
| Antigens, Protozoan | 1 | 2009 | 72 | 0.080 |
Why?
|
| Antibody Affinity | 1 | 2008 | 25 | 0.080 |
Why?
|
| Mutant Proteins | 1 | 2008 | 51 | 0.080 |
Why?
|
| Endemic Diseases | 1 | 2008 | 20 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 132 | 0.080 |
Why?
|
| Fibronectins | 2 | 2017 | 66 | 0.070 |
Why?
|
| Cadherins | 2 | 2017 | 90 | 0.070 |
Why?
|
| Variant Surface Glycoproteins, Trypanosoma | 1 | 2006 | 8 | 0.070 |
Why?
|
| Male | 6 | 2015 | 20025 | 0.070 |
Why?
|
| Metalloproteases | 1 | 2006 | 16 | 0.070 |
Why?
|
| Immunity, Innate | 2 | 2017 | 149 | 0.060 |
Why?
|
| Age Distribution | 1 | 2005 | 225 | 0.060 |
Why?
|
| Trypanosoma brucei brucei | 1 | 2006 | 83 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2006 | 211 | 0.060 |
Why?
|
| Cholera Toxin | 1 | 2024 | 39 | 0.060 |
Why?
|
| Ruminants | 1 | 2023 | 7 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2017 | 444 | 0.060 |
Why?
|
| Kenya | 2 | 2015 | 50 | 0.060 |
Why?
|
| Antigens, Bacterial | 1 | 2024 | 132 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2024 | 362 | 0.050 |
Why?
|
| Chromatography | 1 | 2001 | 16 | 0.050 |
Why?
|
| Immunologic Tests | 1 | 2001 | 11 | 0.050 |
Why?
|
| Lymphogranuloma Venereum | 1 | 2019 | 5 | 0.040 |
Why?
|
| Porins | 1 | 2019 | 19 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2019 | 58 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2019 | 58 | 0.040 |
Why?
|
| Endocytosis | 1 | 2020 | 113 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2019 | 92 | 0.040 |
Why?
|
| Vaccination | 1 | 2021 | 288 | 0.040 |
Why?
|
| Myosin Type II | 1 | 2018 | 18 | 0.040 |
Why?
|
| SOXF Transcription Factors | 1 | 2017 | 2 | 0.040 |
Why?
|
| NFATC Transcription Factors | 1 | 2017 | 6 | 0.040 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 24 | 0.040 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2017 | 18 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2017 | 53 | 0.040 |
Why?
|
| Administration, Rectal | 1 | 2017 | 18 | 0.040 |
Why?
|
| Pyruvic Acid | 1 | 2017 | 18 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 67 | 0.040 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2017 | 2 | 0.040 |
Why?
|
| eIF-2 Kinase | 1 | 2017 | 14 | 0.040 |
Why?
|
| Actins | 1 | 2017 | 148 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2017 | 52 | 0.040 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 70 | 0.040 |
Why?
|
| Endoribonucleases | 1 | 2017 | 23 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2017 | 132 | 0.040 |
Why?
|
| Collagen | 1 | 2017 | 172 | 0.040 |
Why?
|
| Models, Biological | 1 | 2020 | 677 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2015 | 22 | 0.030 |
Why?
|
| Thrombospondin 1 | 1 | 2015 | 23 | 0.030 |
Why?
|
| Caspases | 1 | 2015 | 147 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 90 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2015 | 79 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2015 | 52 | 0.030 |
Why?
|
| Vaccines, Synthetic | 1 | 2015 | 72 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 409 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 132 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2015 | 51 | 0.030 |
Why?
|
| Proteomics | 1 | 2017 | 325 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2019 | 540 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2017 | 513 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 2015 | 107 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 356 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 864 | 0.030 |
Why?
|
| Mitochondria | 1 | 2017 | 487 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 1518 | 0.030 |
Why?
|
| Dihydropteroate Synthase | 1 | 2012 | 1 | 0.030 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2012 | 9 | 0.030 |
Why?
|
| DNA, Protozoan | 1 | 2012 | 24 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 357 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2012 | 98 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 448 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2015 | 681 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 474 | 0.020 |
Why?
|
| Phytohemagglutinins | 1 | 2009 | 13 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2009 | 88 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2009 | 250 | 0.020 |
Why?
|
| Inflammation | 1 | 2013 | 618 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 767 | 0.020 |
Why?
|
| Glycosylphosphatidylinositol Diacylglycerol-Lyase | 1 | 2006 | 1 | 0.020 |
Why?
|
| Phosphatidylinositol Diacylglycerol-Lyase | 1 | 2006 | 5 | 0.020 |
Why?
|
| Life Cycle Stages | 1 | 2006 | 29 | 0.020 |
Why?
|
| Logistic Models | 1 | 2009 | 923 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2009 | 1130 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2002 | 111 | 0.010 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2001 | 12 | 0.010 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2001 | 13 | 0.010 |
Why?
|
| Rural Health Services | 1 | 2001 | 44 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 562 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2001 | 935 | 0.010 |
Why?
|
| Time Factors | 1 | 2001 | 1742 | 0.010 |
Why?
|